BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25350366)

  • 1. Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men.
    Daurignac E; Leonard KE; Dubovsky SL
    Int Clin Psychopharmacol; 2015 Jan; 30(1):23-8. PubMed ID: 25350366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased food intake and energy expenditure following administration of olanzapine to healthy men.
    Fountaine RJ; Taylor AE; Mancuso JP; Greenway FL; Byerley LO; Smith SR; Most MM; Fryburg DA
    Obesity (Silver Spring); 2010 Aug; 18(8):1646-51. PubMed ID: 20134408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK; Rehan HS; Unni KE; Gupta N
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
    Ballon JS; Pajvani UB; Mayer LE; Freyberg Z; Freyberg R; Contreras I; Rosenbaum M; Leibel RL; Lieberman JA
    J Psychopharmacol; 2018 May; 32(5):533-540. PubMed ID: 29444618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone treatment of olanzapine-induced weight gain in healthy men.
    Gross C; Blasey CM; Roe RL; Allen K; Block TS; Belanoff JK
    Adv Ther; 2009 Oct; 26(10):959-69. PubMed ID: 19888560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of olanzapine-induced weight gain with an increase in body fat.
    Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW
    Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
    Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.
    Albaugh VL; Singareddy R; Mauger D; Lynch CJ
    PLoS One; 2011; 6(8):e22662. PubMed ID: 21857944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
    Park S; Yi KK; Kim MS; Hong JP
    Behav Brain Funct; 2013 Jul; 9():27. PubMed ID: 23866300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.
    Assunção SS; Ruschel SI; Rosa Lde C; Campos JA; Alves MJ; Bracco OL; de Lima MS
    Braz J Psychiatry; 2006 Dec; 28(4):270-6. PubMed ID: 17242805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
    Kryzhanovskaya LA; Xu W; Millen BA; Acharya N; Jen KY; Osuntokun O
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):157-65. PubMed ID: 22372514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study.
    Modabbernia A; Heidari P; Soleimani R; Sobhani A; Roshan ZA; Taslimi S; Ashrafi M; Modabbernia MJ
    J Psychiatr Res; 2014 Jun; 53():133-40. PubMed ID: 24607293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
    Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
    Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
    Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
    Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.